SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-20-027372
Filing Date
2020-09-18
Accepted
2020-09-18 16:35:24
Documents
1
Period of Report
2020-09-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 3889
  Complete submission text file 0001213900-20-027372.txt   5520
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 29 EMMONS DRIVE, SUITE B-10 PRINCETON NJ 08540
Business Address
Parks Diane L. (Reporting) CIK: 0001781026 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14778 | Film No.: 201184356